- Home
- BHRB vs ANNX Comparison
BHRB vs ANNX Comparison
Compare BHRB & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHRB | ANNX |
|---|---|---|
| Founded | 1852 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.8M | 812.7M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BHRB | ANNX |
|---|---|---|
| Price | $62.94 | $5.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $71.80 | $16.50 |
| AVG Volume (30 Days) | 127.7K | ★ 2.0M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ 173.76 | N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.62 | N/A |
| Revenue Next Year | $10.06 | $16,320.74 |
| P/E Ratio | $35.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $55.42 | $1.85 |
| 52 Week High | $70.90 | $7.18 |
Technical Indicators
Market Signals| Indicator | BHRB | ANNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 44.52 |
| Support Level | $61.14 | $5.28 |
| Resistance Level | $67.47 | $5.61 |
| Average True Range (ATR) | 1.17 | 0.30 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 55.16 | 40.34 |
Price Performance
Historical ComparisonAbout BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.